The store will not work correctly when cookies are disabled.
5-[4-(Diethylamino)phenyl]-3-methylisoxazolo[4,3-c]quinolin-4(5H)-one
ID: ALA4449660
PubChem CID: 155520528
Max Phase: Preclinical
Molecular Formula: C21H21N3O2
Molecular Weight: 347.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCN(CC)c1ccc(-n2c(=O)c3c(C)onc3c3ccccc32)cc1
Standard InChI: InChI=1S/C21H21N3O2/c1-4-23(5-2)15-10-12-16(13-11-15)24-18-9-7-6-8-17(18)20-19(21(24)25)14(3)26-22-20/h6-13H,4-5H2,1-3H3
Standard InChI Key: LKBNZWZVXBEUMK-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
3.7485 -14.2889 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0009 -15.0703 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.8222 -15.0705 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3066 -15.7358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4097 -13.8087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0753 -14.2872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8204 -13.9556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9063 -13.1402 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.4935 -12.9943 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2405 -12.6596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3307 -11.8450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6664 -11.3642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9140 -11.6997 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8316 -12.5133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6564 -12.8024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3191 -13.2857 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0686 -12.9527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1532 -12.1348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4821 -11.6512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7352 -11.9868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9028 -11.7961 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.5695 -12.2785 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9858 -10.9790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7354 -10.6443 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3192 -11.9397 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4859 -14.4355 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 1 2 0
1 2 1 0
2 3 1 0
3 6 2 0
3 4 1 0
5 6 1 0
5 9 1 0
6 7 1 0
7 8 1 0
8 10 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
8 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
21 22 1 0
21 23 1 0
23 24 1 0
22 25 1 0
7 26 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 347.42 | Molecular Weight (Monoisotopic): 347.1634 | AlogP: 4.29 | #Rotatable Bonds: 4 |
Polar Surface Area: 51.27 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 5.11 | CX LogP: 4.03 | CX LogD: 4.03 |
Aromatic Rings: 4 | Heavy Atoms: 26 | QED Weighted: 0.55 | Np Likeness Score: -1.47 |
References
1. Jumppanen M, Kinnunen SM, Välimäki MJ, Talman V, Auno S, Bruun T, Boije Af Gennäs G, Xhaard H, Aumüller IB, Ruskoaho H, Yli-Kauhaluoma J.. (2019) Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators., 62 (17): [PMID:31431011] [10.1021/acs.jmedchem.9b01086] |